Order or notice
Maharashtra FDA seizes Divya Pharmacy products over cure claims (Jun 2026)
Last checked 10 October 2026
In Jun 2026 Maharashtra FDA seized about Rs 51 lakh of Divya Pharmacy products for 'miraculous cure' claims under the Drugs and Magic Remedies Act; Patanjali went to the Bombay High Court and the state said it would take no coercive action for the time being.
- Classification
- Regulatory notice or advisory
- Decided by
- Maharashtra Food and Drug Administration
- Reference
- Drugs and Magic Remedies (Objectionable Advertisements) Act 1954; Bombay High Court petition by Patanjali (reported); no order published
- Latest action
- 13 June 2026
- Last checked
- 10 October 2026
Photo: An Ayurvedic Pharmacy, Rishikesh (1).jpg by Ken Wieland from Philadelphia, USA (CC BY-SA 2.0). All photo credits.
Drugs and Magic Remedies (Objectionable Advertisements) Act 1954 (full text)
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Products seized
- Drushti Eye Drop, Giloy Ghan Vati, Kutaj Ghan Vati, Cystogrit Diamond, Neurogrit Gold
- Value
- About Rs 51 lakh
- Ground
- 'Miraculous cure' claims, under the Drugs and Magic Remedies Act 1954 (an advertising law)
- Court
- Patanjali moved the Bombay High Court; the state said it would take no coercive action for the time being
In Jun 2026 Maharashtra FDA carried out statewide raids and seized about Rs 51 lakh of Divya Pharmacy products. The products named were Drushti Eye Drop, Giloy Ghan Vati, Kutaj Ghan Vati, Cystogrit Diamond and Neurogrit Gold. The ground was 'miraculous cure' claims, under the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954.
Patanjali moved the Bombay High Court. According to ThePrint, the state told the court it would take no coercive action for the time being. We found no published order from the court or from the FDA, and the exact dates are not given in the source we read.
A seizure under an advertising law is not a ban on a product or on the brand.
What this means for you
A seizure is not a ban
Stock was seized over advertising claims. No order bans a product, and the state has told the court it will not act coercively for now.
It is about claims, not quality
The DMR Act concerns what an advertisement says a drug cures. The seizure does not report a lab-test failure.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Is the Bombay High Court case decided?
The sources we read do not report a decision. They report that the state told the court it would take no coercive action for the time being.
Official sources and primary records
- News
- Gazette